Wednesday, August 17, 2016

BRIEF-Cytokinetics expects results from VITALITY-ALS in 2H 2017

* Cytokinetics completes enrollment in VITALITY-ALS, phase 3

clinical trial of Tirasemtiv in patients with ALS

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)